Sweet Julie Spellman

CEO Sweet Julie Spellman sold 6,057 shares for $1,461,101.58 at ACN; stock down -14.2% in 30 days

CEO Sweet Julie Spellman executed 6 separate sales totaling 6,057 shares for $1,461,101.58 on 2026-02-10, reducing her holdings by 28.4% to 15,255 shares post-transaction. The sales occurred across a narrow price range ($236.11–$243.15), with a blended average of $241.23, while the current price sits at $240.86—suggesting these were disciplined executions near prevailing levels. The timing context is material: ACN has fallen 14.2% over the prior 30 days and 39.5% from its 52-week high of $398.25, despite solid fundamentals (revenue $18.7B, net income $2.2B, P/E 20.16). Spellman's same-ticker history shows 5 consecutive sells on 2026-02-03 (outcomes not yet measurable), indicating sustained portfolio reduction activity rather than a one-off event. Her cross-ticker track record across 20 prior sells shows mixed timing (36.36% well-timed rate), so this filing should be monitored against post-sale price action to assess whether the reduction signals forward-looking caution in a declining equity or simply portfolio management.

CEO Sweet Julie Spellman sold 5,500 shares of ACN for $1,333,120.52 in 9 separate transactions on 2026-02-03.

Sweet Julie Spellman, Chair and CEO, executed 9 separate sales totaling 5,500 shares for $1,333,120.52 on 2026-02-03, reducing her holdings by -20.6% from 26,650 to 21,150 shares. The blended average price of $242.39 is $1.26 above the current price of $241.65, placing the transaction near recent levels. Her same-ticker trade history shows a marked contrast: 4 of 5 prior sells at ACN registered negative 90-day returns, indicating well-timed exits before subsequent declines. At the current price of $241.65, the stock trades -39.3% from its 52-week high of $398.25 and -8.5% over the past 30 days. The CEO's cross-ticker track record shows 20 prior sells with a 45.00% well-timed rate, while her ACN-specific pattern of 4 of 5 prior sells followed by 90-day declines suggests deliberate timing discipline at this particular ticker.

ACN Chair/CEO Julie Spellman sells 5,917 shares for $1,459,276.66 across 4 transactions at $246.62 avg; stock now down 3.9% in 30 days

Julie Spellman, Chair and CEO of Accenture plc, executed 4 separate sales on 2025-11-05 totaling 5,917 shares for $1,459,276.66 at a blended average price of $246.62, reducing her holding by 40.3% from 14,673 to 8,756 shares. The sales occur as ACN trades at $241.34, down 3.9% over the past 30 days and 39.4% below its 52-week high of $398.25, creating a gap between the blended transaction prices ($246.62) and current market levels. Spellman's cross-ticker track record shows prior sells averaged -3.0% returns within 30 days and -5.4% within 90 days, with a 50.00% well-timed rate; her five prior trades at ACN remain unmeasurable in outcome, having all occurred within the past two weeks. This multi-sale pattern on a single date warrants attention to the timing context and company fundamentals, though the outcome cannot yet be assessed against the historical pattern.

CEO Sweet Julie Spellman sells 9,000 ACN shares for $2.3M across 4 transactions on 2025-10-29

Sweet Julie Spellman, Chair and CEO, executed 4 separate sales totaling 9,000 shares for $2,280,586.99 on 2025-10-29 at a blended average price of $253.40, reducing her holdings by 38.3%. The current stock price of $249.25 is 37.4% below the 52-week high of $398.25, reflecting meaningful pullback from peak valuation despite Accenture's solid fundamentals (revenue $17.7B, net income $2.2B, 7.4% annual revenue growth, P/E 18.98). Spellman's cross-ticker track record shows 20 prior sells with a 62.50% well-timed rate at the 90-day mark, though her prior trades at ACN (5 distinct positions) show mixed timing—only 1 of 1 measurable sales was well-timed (the July 2025 sale with -11.1% 90-day return), while 4 more recent sales from October 22 lack measurable outcome windows. The concentration of sales in late October during a period of 30-day weakness (-2.4% over 90 days) warrants attention to whether this reflects a planned divestiture or discretionary timing.

Accenture CEO Julie Spellman sold 9,000 shares for $2.2M; 5 of 5 prior same-ticker sales were well-timed.

Julie Spellman (Chair and CEO) executed 4 separate sales totaling 9,000 shares for $2,246,165.56 at a blended average price of $249.57 on 2025-10-22, reducing her holdings from 32,516 to 23,516 shares (a -27.7% reduction). This sale occurs while ACN trades at $249.81, near its transaction price but -37.3% below its 52-week high of $398.25 and -11.8% below its 90-day price level. Notably, all 5 of Spellman's prior same-ticker sales (on 2025-07-11) were well-timed at the 90-day mark, with negative returns of -15.6% to -16.7% over 90 days, indicating a consistent pattern of selling into declines. The company's fundamentals remain solid (P/E of 19.03, $17.7B quarterly revenue, +7.4% annual growth), but the insider's historical accuracy at this ticker and the current stock price positioning relative to the 52-week range merit investor attention.

ACN CEO Julie Spellman sold 2,251 shares for $635,789.50 on 2025-07-11; post-sale holding 8,109 shares (-21.7%)

Sweet Julie Spellman, Chair and CEO of Accenture plc, executed 5 separate sales totaling 2,251 shares for $635,789.50 on 2025-07-11 at an average price of $282.45. This represents a -21.7% reduction in her post-transaction holdings (from 10,360 to 8,109 shares). At the current price of $279.99, the stock is -29.7% below its 52-week high of $398.25 and has declined -10.2% over the past 30 days. Notably, her prior five trades at ACN (all conducted on 2025-04-11) saw subsequent stock appreciation at the 90-day mark, with none of those sales proving well-timed by her track record; her cross-ticker open-market history shows a 60.00% well-timed rate on sells. The substantial reduction in her shareholding during a period of price weakness—coupled with her historically mixed timing record at this specific ticker—provides material context for investor monitoring.

Chair/CEO Spellman sold 2,284 shares at blended $281.63 for $643,253.54 on 2025-04-11.

Julie Spellman, Chair and CEO of Accenture plc, executed 6 separate sales totaling 2,284 shares for $643,253.54 on April 11, 2025, at prices ranging from $278.98 to $284.48, reducing her holdings from 12.2K to 10.0K shares (-18.6%). The sales occurred as ACN traded within its 52-week range ($281.39–$398.25) but down 27.2% from the 52-week high and 9.1% lower over the preceding 30 days. Spellman's same-ticker trade history at ACN shows 5 prior sales on 2025-02-05, all of which have declined 12.5% to 13.6% in the 30 days following their execution. The volume of this transaction relative to remaining holdings and the sustained negative price momentum following her most recent trades at this ticker merit monitoring, though the timing cannot be characterized without knowledge of any 10b5-1 plan governing this execution.

ACN Chair & CEO Julie Spellman sells 8,793 shares for $3,468,538.80 across 6 transactions on 2025-02-05.

Julie Spellman, Chair and CEO of Accenture plc, executed 6 separate sales totaling 8,793 shares for $3,468,538.80 on 2025-02-05, reducing her holdings by 42.4% from 20,749 to 11,956 shares. The blended average transaction price of $394.47 sits near the 52-week high of $398.25 (-2.7%), and the stock has appreciated 8.7% over the prior 30 days and 9.0% over 90 days. Her cross-ticker track record shows a 90-day well-timed rate of 41.18%, slightly below the 50% benchmark for random timing; at ACN specifically, her prior 5 trades yield a 50% well-timed rate at 90 days. This large, concentrated sale by the chief executive warrants monitoring in the context of the company's premium valuation (P/E 32.60) and recent positive momentum, though the timing near recent highs and the absence of a 10b5-1 plan flag in the filing details suggests discretionary execution.

ACN CEO Sweet Julie Spellman sold 2,497 shares for $885,142.93 across 3 transactions on 2025-01-17.

CEO Sweet Julie Spellman executed 3 separate sales totaling 2,497 shares for $885,142.93 at blended average price $354.48 on 2025-01-17, reducing her holdings by 8.0% from 31,363 shares to 28,866 shares. The timing coincided with ACN trading -7.9% from its 52-week high and -2.7% over the prior 30 days, and the insider's cross-ticker track record shows an average 90-day return of +7.4% following her prior 20 sells, indicating her past sales have generally preceded stock gains rather than declines. At the same ticker, her 5 prior sales (all on 2024-10-28) showed a 0% well-timed rate at the 90-day mark, offering no predictive pattern specific to ACN; the current filing is routine portfolio activity by a major shareholder of a $227.0B company at stable valuation metrics (P/E 30.00, annual revenue growth +1.2%).

ACN CEO Julie Spellman sold 8,136 shares for $2,945,768.03 in 6 transactions on 2024-10-28, reducing holdings by 40.0%

Julie Spellman, Chair and CEO of Accenture plc, executed 6 separate sales totaling 8,136 shares for $2,945,768.03 at an average price of $362.07 on 2024-10-28, reducing her holdings from 20,324 shares to 12,188 shares. This represents a 40.0% reduction in her position. At the same-ticker level, Spellman's two most recent sales on 2024-07-12 were followed by 30-day and 90-day gains (+5.4% and +20.5%, +2.2% and +16.8% respectively), and her cross-ticker track record shows an average 90-day return of +3.7% after sells with a 90d well-timed rate of 52.94%. The sale occurred while ACN trades at $363.04, within its 52-week range and up 3.8% over 30 days and 9.8% over 90 days, though down 6.2% from its 52-week high of $386.91. The magnitude of the stake reduction and timing relative to recent company price momentum merit investor attention to any accompanying disclosures regarding strategic intent or liquidity needs.